Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > QGEN Qiagen NV > Main Composition
QGEN Qiagen NV
49.250
+0.280+0.57%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Consumables and related revenues--1.99B88.22%
Instruments--265.35M11.78%
Region Unit:USD
nameYOYOperating income%
United States--909.69M40.40%
Europe, Middle East and Africa--814.42M36.17%
Asia Pacific, Japan and Rest of World--429.86M19.09%
Other Americas--97.69M4.34%
Company Overview More
QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The firm automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D, and industrial applications, primarily forensics). The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
CEO: Mr. Thierry Bernard
Market: NYSE
Listing Date: 07/03/2006
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist